BOXIONG TANG, AVP, Head of HEOR & Medical Value Access, Agenus

•   Dr. Tang brings over 25 years experiences in medicine, public health, and health economics & outcomes research (HEOR).

•   Currently, he is the Associate Vice President, Head of HEOR and Medical Value Access at Agenus, responsible for developing HEOR function and implementing health outcomes research strategies globally. He established HEOR function to support the product launches and reimbursement globally.

•   Before joining Agenus, Dr. Tang has served as an Executive Director of HEOR at BeiGene, Sr. Director of Global HEOR at Teva Pharmaceutical. Senior Director of Health Outcomes Research at Pfizer Emerging Markets, Director of HEOR in JNJ and GSK.

•   He was also an adjuvant professor of China Fudan University and faculty of Zhejiang University Medical School. Meanwhile, Dr. Tang was the 2016-2018 Chair of the HTA (Industry) Committee, Asia Consortium of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and a current member of Asia Consortium Executive Committee. Also, he served as a Sr. Fellow at Thomas Jefferson University, School of Population Health.

•   Dr. Tang’s training includes a MD in Preventive Medicine, a PhD in Health Services Research, and a MPH in Health Planning and International Health.

•   He has published more than 40 manuscripts in peer review journals, 100+ abstracts, speeches and presentations in major scientific congresses. He is knowledgeable in the development of Health Technology Assessment around the world. In addition, he served at Scientific Committees of International Health Economics Association (iHEA/ASHE), Society for Medical Decision Making (SMDM), and a Peer Reviewer of America Journal of Managed Care, and Cancer Research Journal.